» Articles » PMID: 31001254

Donor Allospecific CD44 Central Memory T Cells Have Decreased Ability to Mediate Graft-vs.-Host Disease

Overview
Journal Front Immunol
Date 2019 Apr 20
PMID 31001254
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Data from both animal models and humans have demonstrated that effector memory T cells (T) and central memory T cells (T) from unprimed donors have decreased ability to induce graft-vs-host disease (GVHD). Allospecific T from primed donors do not mediate GVHD. However, the potential of alloreactive T to induce GVHD is not clear. In this study, we sought to answer this question using a novel GVHD model induced by T cell receptor (TCR) transgenic OT-II T cells. Separated from OT-II mice immunized with OVA protein 8 weeks earlier, the allospecific CD44 T were able to mediate skin graft rejection after transfer to naive mice, yet had dramatically decreased ability to induce GVHD. We also found that these allospecific CD44 T persisted in GVHD target organs for more than 30 days post-transplantation, while the expansion of these cells was dramatically decreased during GVHD, suggesting an anergic or exhausted state. These observations provide insights into how allospecific CD4 T respond to alloantigen during GVHD and underscore the fundamental difference of alloresponses mediated by allospecific T in graft rejection and GVHD settings.

Citing Articles

Combining molecular characteristics and therapeutic analysis of PDOs predict clinical responses and guide PDAC personalized treatment.

Li P, Huang M, Li M, Li G, Ma Y, Zhao Y J Exp Clin Cancer Res. 2025; 44(1):72.

PMID: 40001264 PMC: 11863571. DOI: 10.1186/s13046-025-03332-8.


Kinetics of Recovery of Naïve and Memory T Cells in Acute Leukemia Patients after Allogeneic Stem Cell Transplantation Depending on Different GVHD Prophylaxis Regimens.

Popova N, Drokov M, Davydova Y, Kapranov N, Vasilieva V, Galtseva I Int J Hematol Oncol Stem Cell Res. 2024; 18(1):33-46.

PMID: 38680716 PMC: 11055426. DOI: 10.18502/ijhoscr.v18i1.14742.


TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses.

Harris R, Mammadli M, Hiner S, Suo L, Yang Q, Sen J Cancer Immunol Immunother. 2022; 72(6):1581-1601.

PMID: 36562825 PMC: 10198945. DOI: 10.1007/s00262-022-03323-0.


Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?.

Dekker L, Sanders E, Lindemans C, de Koning C, Nierkens S Front Immunol. 2022; 13:893545.

PMID: 35795679 PMC: 9250980. DOI: 10.3389/fimmu.2022.893545.


Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity.

Song Q, Nasri U, Nakamura R, Martin P, Zeng D Front Immunol. 2022; 13:907673.

PMID: 35677056 PMC: 9168269. DOI: 10.3389/fimmu.2022.907673.


References
1.
Dey B, Yang Y, Preffer F, Shimizu A, Swenson K, Dombkowski D . The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation. 1999; 68(1):141-9. DOI: 10.1097/00007890-199907150-00026. View

2.
Yu X, Bidwell S, Martin P, Anasetti C . Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction. J Immunol. 1999; 163(9):4780-7. View

3.
Anderson B, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik M . Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest. 2003; 112(1):101-8. PMC: 162285. DOI: 10.1172/JCI17601. View

4.
Bingaman A, Farber D . Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant. 2004; 4(6):846-52. DOI: 10.1111/j.1600-6143.2004.00453.x. View

5.
Yu X, Albert M, Anasetti C . Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells. J Immunol. 2006; 176(6):3383-90. DOI: 10.4049/jimmunol.176.6.3383. View